
5001 - 10000 employees
Founded 1915
💊 Pharmaceuticals
🧬 Biotechnology
💰 $566.4M Post-IPO Debt - Lundbeck on 2025-05
Pharmaceuticals • Biotechnology
Lundbeck is a global pharmaceutical company specializing exclusively in brain diseases and neuroscience. With more than 70 years of expertise, Lundbeck researches, develops, and commercializes therapies for neurology and psychiatry conditions — including Alzheimer's, Parkinson's, migraine, epilepsy (Lennox‑Gastaut), depression, schizophrenia, bipolar disorder, PTSD, and substance use disorders. The company runs clinical trials, maintains an active R&D pipeline and medical education initiatives, and partners with external innovators while emphasizing patient centricity, sustainability, and global operations from its Denmark headquarters.
🕒 June 26
Director of Medical Affairs Scientific Communications at Lundbeck developing strategies for MSA. Overseeing publication planning and cross-functional collaboration to support launch readiness.
🌽 Illinois – Remote
💵 $260k - $290k / year
💰 $566.4M Post-IPO Debt - Lundbeck on 2025-05
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
🕒 June 22
Senior Director managing HCP & Payer Marketing for Rare Epilepsy portfolio at Lundbeck. Leading marketing strategies, team collaborations, and patient engagement initiatives.
🌽 Illinois – Remote
💵 $280k - $315k / year
💰 $566.4M Post-IPO Debt - Lundbeck on 2025-05
⏰ Full Time
🟠 Senior
🎡 Marketing